Table 3.
Results of liver enzyme and function testing at the end of observation.
| PBC(N=226) | PBC/SS(N=56) | P value | |
|---|---|---|---|
| TB (μmol/L) | 16.1(11.4,27.7) | 15.4(10.1,30.7) | 0.392 |
| ALT (IU/L) | 29.0(19.0,45.3) | 29.0(21.3,36.8) | 0.557 |
| AST (IU/L) | 39.5(30.0,58.3) | 36.0(30.0,54.5) | 0.529 |
| ALP (IU/L) | 145.5(111.3,224.5) | 131.5(103.3,189.8) | 0.176 |
| GGT (IU/L) | 53.0(33.8,127.5) | 59.0(30.3,94.3) | 0.639 |
| Alb (g/L) | 42.8(35.0,46.5) | 42.7(34.7,46.4) | 0.973 |
| PLT (×109/L) | 126.0(71.8,182.3) | 94.0(59.8,175.3) | 0.112 |
| INR | 1.0(0.9,1.2) | 1.0(0.9,1.1) | 0.998 |
| Fib-4 | 3.0(1.8,6.8) | 4.0(1.9,8.8) | 0.254 |
| APRI | 0.9(0.4,1.6) | 1.0(0.5,2.1) | 0.489 |
Data are expressed as the median (interquartile range); TB, total bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase; Alb, albumin; PLT, platelet; INR, international normalized ratio; Fib-4, fibrosis score; APRI, aspartate aminotransferase/platelet ratio index; SS, Sjögren's syndrome; and PBC, primary biliary cholangitis.